Medtronic PLC has entered the European market with its first recapturable, repositionable transcatheter aortic valve with the Sept. 3 CE mark of its 23 mm CoreValve Evolut R device.
The valve will compete directly in Europe with other second-generation, repositionable valves, including Boston Scientific Corp.Lotus, valves from Direct Flow Medical Inc. and St. Jude Medical Inc.’s...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?